Fed. Circ. OKs PTAB Save Of Patent Covering Pfizer's Toviaz
The Federal Circuit ruled Friday that a patent on Pfizer Inc.'s incontinence drug Toviaz was correctly upheld in an inter partes review challenge from generics maker Amerigen Pharmaceuticals Ltd., while rejecting...To view the full article, register now.
Already a subscriber? Click here to view full article